News & Events

Events

WCBP

Jan 23-25
Washington, DC

OTx Xchange

Feb 28
Manchester Grand Hyatt San Diego, CA

AACR

April 5-10
San Diego, CA

BEBPA HCP

May 14-16
College Park, MD

ADLM

July 30-Aug 1
Chicago, IL

BPS

Aug 19-22
Boston, MA

OTS

Oct 6-9
Montreal, Quebec, Canada

SfN

Oct 5-9
Chicago, IL

MEDICA

Nov 11-14
Messe Dusseldorf Dusseldorf, Germany

News

APRIL 16, 2024
Rockland, antibodies-online, and The Jackson Laboratory Partner to Exclusively Offer Innovative Genome Editing Tools to Researchers Worldwide
The Jackson Laboratory partners with Rockland and antibodies-online to provide genomic tools for global immuno-oncology research, diagnostics, and therapeutics development.
JANUARY 11, 2024
Rockland Launches Impurity Detection Kit for Accurate Measurement of Nuclease Across a Spectrum of Therapeutic Manufacturing Methods
The AccuSignal Nuclease ELISA Kit is designed to detect endonuclease to evaluate manufacturing processes for biological therapeutics, gene therapy vectors, vaccine preparations, and more.
OCTOBER 17, 2023
Rockland Launches Novel Analytical Tools to Assess Drug Delivery Revolutionizing Oligonucleotide Therapeutic Development
The first and only panel of specialty reagents designed to detect PS modifications independent of sequence, format, or location, streamlining candidate triage for unparalleled cost and time savings in early-stage non-clinical and pre-clinical discovery assessment of...
FEBRUARY 1, 2023
Rockland Launches Early Access Program for ModDetect™ Anti-PS Panel
Rockland, a pioneer in life science solutions, is excited to announce the initiation of the Early Access Program for its ModDetect™ Anti-PS Monoclonal Antibody Panel.
NOVEMBER 10, 2022
Rockland Immunochemicals, Inc. and Cytiva Life Sciences to launch PrismA ELISA Kit
In partnership with Cytiva Life Sciences, Rockland is announcing the newest addition to the portfolio - the PrismA ELISA kit. This new kit is designed to reduce the complexity in process-related impurity analytical assay development.
FEBRUARY 22, 2022
Rockland Immunochemicals, Inc. collaborates with Jefferson Institute for Bioprocessing to offer complete bioprocessing solutions
Rockland Immunochemicals, Inc. (Rockland) and the Jefferson Institute for Bioprocessing (JIB) announced today that an agreement has been signed under which both entities are able to utilize one another's strengths to provide complete and scalable bioprocessing solutio...
FEBRUARY 10, 2022
Rockland Immunochemicals, Inc. announces acquisition of antibodies-online GmbH and investment from BroadOak Capital Partners
With its acquisition of antibodies-online GmbH, Rockland expands its capabilities, product portfolio, and geographic footprint to serve scientists engaged in the discovery, development, and delivery of complex therapies and critical diagnostics ...
OCTOBER 18, 2021
Rockland expands infectious disease portfolio with new partner, Diagnostic BioSystems
Diagnostic BioSystems (DBS), a provider of cutting-edge in vitro diagnostics and high quality Immunohistochemistry (IHC) reagents has signed a distribution agreement with Rockland Immunochemicals, Inc ...
SEPTEMBER 28, 2021
From Philadelphia to Saudi Arabia: A partnership in support of biotech expansion
Rockland President and Chief Executive Officer, James Fendrick and the King Abdullah International Medical Research Center (ك KAIMRC) recently signed a Memorandum ...
SEPTEMBER 9, 2020
Unique Scientific-Academic Partnership Advances Revolutionary CRISPR in a Box™ Educational Gene Editing Kit
Introducing CRISPR in a Box - it is not a new crunchy cereal or the latest snack - it is an educational tool kit consisting of state-of-the-science gene editing technology that could be coming to a school near you ...
AUGUST 12, 2020
Rockland Employees Working on COVID-19 Antibody Development Featured in Recent Article by Montgomery County Community College
Rockland greatly values our local partnerships-one in particular is our partnership with Montgomery County Community College (MCCC) and their Biotechnology Associate Professor and Program Coordinator, Dr. Margaret Bryans ...
MAY 29, 2020
Rockland Develops Antibody Proven to Detect SARS-CoV-2 in Patient Samples
Rockland Immunochemicals Inc. has developed a critical antibody reagent essential to antibody tests used to determine SARS-CoV-2 exposure for patients suspected to have contracted COVID-19 ...
MARCH 16, 2020
COVID-19: An Important Update
At Rockland, we are adjusting our business operations to account for the coronavirus (COVID-19) pandemic. We want you, our customers, to know our plans ...
Load More